HealthEquity, Inc. $HQY Shares Sold by Farallon Capital Management LLC

Farallon Capital Management LLC reduced its stake in shares of HealthEquity, Inc. (NASDAQ:HQY) by 98.4% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,000 shares of the company’s stock after selling 314,800 shares during the period. Farallon Capital Management LLC’s holdings in HealthEquity were worth $474,000 as of its most recent SEC filing.

Several other hedge funds have also modified their holdings of HQY. Simplify Asset Management Inc. purchased a new position in HealthEquity during the third quarter worth approximately $1,498,000. 12th Street Asset Management Company LLC boosted its holdings in shares of HealthEquity by 114.4% in the 3rd quarter. 12th Street Asset Management Company LLC now owns 272,068 shares of the company’s stock valued at $25,784,000 after purchasing an additional 145,151 shares during the last quarter. Oppenheimer Asset Management Inc. grew its stake in shares of HealthEquity by 45.5% during the 3rd quarter. Oppenheimer Asset Management Inc. now owns 155,543 shares of the company’s stock valued at $14,741,000 after buying an additional 48,621 shares during the period. Bessemer Group Inc. grew its stake in shares of HealthEquity by 21.3% during the 3rd quarter. Bessemer Group Inc. now owns 349,342 shares of the company’s stock valued at $33,108,000 after buying an additional 61,317 shares during the period. Finally, GDS Wealth Management increased its holdings in shares of HealthEquity by 15.7% during the 3rd quarter. GDS Wealth Management now owns 100,969 shares of the company’s stock worth $9,569,000 after buying an additional 13,682 shares during the last quarter. 99.55% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on the company. BTIG Research cut their target price on HealthEquity from $130.00 to $110.00 and set a “buy” rating on the stock in a research report on Tuesday, February 17th. UBS Group set a $110.00 price target on HealthEquity in a research note on Tuesday, February 17th. KeyCorp raised their price objective on HealthEquity from $120.00 to $125.00 and gave the stock an “overweight” rating in a report on Thursday, January 8th. JPMorgan Chase & Co. lifted their price objective on HealthEquity from $126.00 to $129.00 and gave the company an “overweight” rating in a research note on Thursday, December 4th. Finally, Citizens Jmp set a $122.00 target price on HealthEquity in a report on Thursday, December 4th. One equities research analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $112.00.

HealthEquity Trading Up 1.3%

Shares of HQY opened at $77.81 on Monday. HealthEquity, Inc. has a 12 month low of $72.76 and a 12 month high of $116.65. The stock’s 50-day moving average is $81.91 and its two-hundred day moving average is $90.41. The company has a debt-to-equity ratio of 0.46, a current ratio of 4.13 and a quick ratio of 4.13. The stock has a market cap of $6.65 billion, a PE ratio of 35.69, a P/E/G ratio of 0.97 and a beta of 0.26.

Insider Activity

In related news, EVP Elimelech Rosner sold 10,959 shares of the firm’s stock in a transaction dated Thursday, December 18th. The stock was sold at an average price of $95.45, for a total transaction of $1,046,036.55. Following the sale, the executive vice president directly owned 45,742 shares in the company, valued at approximately $4,366,073.90. This trade represents a 19.33% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Delano Ladd sold 1,500 shares of the business’s stock in a transaction that occurred on Friday, December 19th. The stock was sold at an average price of $94.72, for a total value of $142,080.00. Following the transaction, the executive vice president directly owned 73,979 shares in the company, valued at $7,007,290.88. This trade represents a 1.99% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Company insiders own 1.50% of the company’s stock.

HealthEquity Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.